Lai Fengling, Zhou Kaixin, Ma Yingjie, Lv Hao, Wang Weilin, Wang Rundong, Xu Tao, Huang Rong
Department of Cardiology, Jinan Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Diabetologia. 2025 Apr;68(4):835-853. doi: 10.1007/s00125-024-06341-y. Epub 2024 Dec 19.
AIMS/HYPOTHESIS: Pancreatic beta cell mass is dynamically regulated in response to increased physiological and pathological demands. Understanding the mechanisms that control physiological beta cell proliferation could provide valuable insights into novel therapeutic approaches to diabetes. Here, we aimed to analyse the intracellular and extracellular signalling pathways involved in regulating the physiological proliferation of beta cells using single-cell RNA-seq (scRNA-seq) and in vitro functional assays.
Islets isolated from nulliparous mice, mice at different time points of gestation and mice at day 4 after delivery were analysed using scRNA-seq. Bioinformatics analyses of scRNA-seq data were performed to determine the heterogeneous transcriptomic characteristics of beta cells and to identify the proliferating subpopulation. CellChat was used to analyse cell-cell communication and identify the ligand-receptor pairs between beta cell subclusters as well as between non-beta cells and proliferating beta cells. In vitro functional assays were conducted in mouse and rat beta cell lines and isolated mouse primary islets to validate the role of Kmt5a- mono-methylation of histone H4 at lysine 20 (H4K20me) signalling and endothelial-derived heparin-binding EGF-like growth factor (HBEGF) in beta cell proliferation.
Of 43,724 endocrine and non-endocrine cells within islets analysed by scRNA-seq, 15,569 beta cells were clustered into eight distinct populations, each exhibiting unique heterogeneity. A proliferating beta cell subcluster was identified that highly expressed the histone methyltransferase Kmt5a. Activation of Kmt5a-H4K20me signalling upregulated the expression of Cdk1 and promoted beta cell proliferation. The crosstalk between endothelial cells and the proliferating beta cell subcluster, mediated by the HBEGF-EGF receptor (EGFR) ligand-receptor interaction, increased as beta cell mass expanded. HBEGF increased the expression levels of genes involved in the cell cycle and promoted beta cell proliferation by regulating the Kmt5a-H4K20me signalling pathway.
CONCLUSIONS/INTERPRETATION: Our study demonstrates that, under physiological conditions, endothelial-derived HBEGF regulates beta cell proliferation through the Kmt5a-H4K20me signalling pathway, which may serve as a potential target to promote beta cell expansion and treat diabetes.
The scRNA-seq and RNA-seq datasets are available from the Gene Expression Omnibus (GEO) using the accession numbers GSE278860 and GSE278861, respectively.
目的/假设:胰腺β细胞质量会根据生理和病理需求的增加而动态调节。了解控制生理性β细胞增殖的机制可为糖尿病的新型治疗方法提供有价值的见解。在此,我们旨在使用单细胞RNA测序(scRNA-seq)和体外功能试验分析参与调节β细胞生理性增殖的细胞内和细胞外信号通路。
使用scRNA-seq分析从未生育小鼠、处于不同妊娠时间点的小鼠以及分娩后第4天的小鼠分离出的胰岛。对scRNA-seq数据进行生物信息学分析,以确定β细胞的异质转录组特征并识别增殖亚群。使用CellChat分析细胞间通讯,并识别β细胞亚群之间以及非β细胞与增殖β细胞之间的配体-受体对。在小鼠和大鼠β细胞系以及分离的小鼠原代胰岛中进行体外功能试验,以验证赖氨酸20处组蛋白H4单甲基化(H4K20me)的Kmt5a信号传导和内皮细胞衍生的肝素结合表皮生长因子(HBEGF)在β细胞增殖中的作用。
通过scRNA-seq分析的胰岛内43,724个内分泌和非内分泌细胞中,15,569个β细胞被聚类为八个不同的群体,每个群体都表现出独特的异质性。鉴定出一个增殖性β细胞亚群,其高度表达组蛋白甲基转移酶Kmt5a。Kmt5a-H4K20me信号的激活上调了Cdk1的表达并促进了β细胞增殖。随着β细胞质量的扩大,由HBEGF-表皮生长因子受体(EGFR)配体-受体相互作用介导的内皮细胞与增殖性β细胞亚群之间的串扰增加。HBEGF通过调节Kmt5a-H4K20me信号通路增加了参与细胞周期的基因的表达水平并促进了β细胞增殖。
结论/解读:我们的研究表明,在生理条件下,内皮细胞衍生的HBEGF通过Kmt5a-H4K20me信号通路调节β细胞增殖,这可能作为促进β细胞扩增和治疗糖尿病的潜在靶点。
scRNA-seq和RNA-seq数据集分别可从基因表达综合数据库(GEO)中获取,登录号分别为GSE278860和GSE278861。